In a HealthDay Now interview, we spoke to award-nominated actor, Tony Head, a research participant in a Johns Hopkins clinical trial of psilocybin. Tony was diagnosed with stage 4 prostate cancer in 2011 and he shares how his experience with psilocybin helped him face his fears of dying.
If you're a patient with a weakened immune system, roll up your sleeves to stay safe over the holidays and winter months.
"Immunocompromised patients absolutely should get a flu shot as well as an additional COVID-19 vaccine dose," said Dr. Marwa Kaisey, a neuroimmunologist and assistant professor of neurology at Cedars-Sinai in Los Angel... Full Page
Planning ahead will reduce the risk of allergies and asthma interfering with your holiday plans, an expert says.
"In addition to concerns about COVID-19, those with allergies and asthma sometimes have an added layer of anxiety because they need to always be thinking about allergy and asthma triggers that can cause serious symptoms," said D... Full Page
Robert Preidt and Ernie Mundell HealthDay Reporters
December 3, 2021
Women are two times more likely than men to die after receiving a combination of cancer immunotherapy drugs called checkpoint inhibitors, but it's not clear if that difference is due to side effects or because the treatment isn't working, researchers say.
This new class of highly targeted drugs — which includes pembrolizumab (Keytruda),... Full Page
Health News is provided as a service to Seip Drug site users by HealthDay. Seip Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.